Phase III Randomised Study of Adjuvant Immunotherapy with Monoclonal Antibody 17-1A versus no Adjuvant Therapy following Resection for Stage 2 (Modified Astler-Coller B2) Adenocarcinoma of the Colon

  • Johnson, Philip (Principal Investigator)

Project Details

Short titlePhase III Randomised Study of Adjuvant Immunotherapy with Monoclonal Antibody 17-1A versus no Adjuvant Therapy following Resection for Stage 2 (Modified Astler-Coller B2) Adenocarcinoma of the Colon
StatusFinished
Effective start/end date1/09/99 → 31/12/11

Funding

  • GlaxoSmithKline